Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Area: Information Technology
The Seven Highly Effective Habits of Closed-Loop Compliance
By Patricia Santos-Serrão, QUMAS, Regulatory Advisor, Life Sciences
The challenging world of compliance
Life sciences companies face an increasing level of compliance challenges and pressures as the complex web of regulations continues to multiply. By Kevin O’Leary, QUMAS
The data and knowledge management challenge for late stage and preclinical pharmaceutical research
By Paul Denny-Gouldson, Scott Weiss and Glyn Williams, ID Business Solutions
“All business organisations will benefit”
Talking with Sparta Systems about the benefits of implementing its TrackWise® quality and compliance management software.
Biomark my words
Biomarkers are playing an increasingly important role in the development of new drugs to fight disease. In this revealing interview, Dr Werner Kroll, Global Head of Biomarker Development at Novartis, gives us his view on the development of this exciting new area of medicine.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.